Corticosteroids or ACTH for acute exacerbations in multiple sclerosis

2000203 citationsReviewgreen Open Access

Authors

Antonietta Citterio · Fondazione Istituto Neurologico Nazionale Casimiro Mondino

L. La Mantia · Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

G. Ciucci · Ospedale "Santa Maria delle Croci" di Ravenna

L. Candelise · Ospedale Maggiore

Fabio Brusaferri · Azienda Ospedaliera Ospedale Maggiore

Rune Midgard · Molde Hospital

Graziella Filippini

Abstract

We found evidence favouring the corticosteroid MP for acute exacerbation in MS patients. Data are insufficient to reliably estimate effect of corticosteroids on prevention of new exacerbations and reduction of long-term disability. Studies assessing long term risk/benefit and adverse effects of corticosteroids in MS patients are urgently needed.

Topics & Keywords

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Polyomavirus and related diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cochrane Database of Systematic Reviews

Volume 2013, Issue 11, pp. CD001331-CD001331

DOI: 10.1002/14651858.cd001331

Field-Weighted Citation Impact: 2.38